HIGHLIGHTS
- who: Antonio Riva from the University of Oxford, United Kingdom have published the article: Editorial: Soluble immune checkpoints: Novel physiological immunomodulators, in the Journal: (JOURNAL) of 21/03/2023
- how: The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
SUMMARY
Immune checkpoint, soluble immune checkpoint, immunotherapy, human disease, immunomodulation, novel therapeutic agents ACCEPTED CITATION Riva A Editorial: Soluble immune checkpoints: Novel physiological immunomodulators. 14:1178541. doi: 10.3389/fimmu.2023.1178541 COPYRIGHT Frontiers . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.